Neogen Corp (FRA:NG2)
€ 14.4 0.1 (0.7%) Market Cap: 3.26 Bil Enterprise Value: 3.97 Bil PE Ratio: 0 PB Ratio: 1.12 GF Score: 80/100

Neogen Corp at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 04:15PM GMT
Release Date Price: €15.9 (+1.27%)
Edwin Zhang

Good morning, everyone. Thank you again for joining us. Welcome to the 41st Annual JPMorgan Healthcare Conference. My name is Edwin Zhang. I work in the JPMorgan Healthcare Investment Banking Team in New York and today, our presenting company is Neogen. Please join me in welcoming our presenter, John Adent, CEO and President of Neogen.

John Edward Adent
Neogen Corporation - President, CEO & Director

Thanks for the thunderous round of applause this morning. Normally, at our sales meeting, I put $100 under each seat in front to try to get people to come to the front so you've missed out on that. But I am John Adent, I'll be providing an overview on Neogen. I really appreciate you being here this morning. A quick reminder that we will have some forward-looking statements in this presentation and so my attorney said, please familiarize yourself with this disclaimer.

At Neogen, over the last 40 years, we've been committed to improving food safety across the world's global food supply. Our mission is to be the leading company in the development

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot